-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L5+2hrch+g0g93r4z2g6YYYiQ5Upn8ETVVsHU+gFg+JKNmKQWgLRE0cqIgha6A4B N0E/IdBxmnmJL8uK8X+ONA== 0000950117-03-001607.txt : 20030422 0000950117-03-001607.hdr.sgml : 20030422 20030422172701 ACCESSION NUMBER: 0000950117-03-001607 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030422 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-04802 FILM NUMBER: 03658850 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K 1 a35084.txt BECTON, DICKINSON AND COMPANY SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 22, 2003 -------------- BECTON, DICKINSON AND COMPANY - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - ---------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - ---------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - -------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 5. Other Events and Regulation FD Disclosure. On April 22, 2003, the Registrant issued the press release that is attached hereto as Exhibit 99.1. Item 7. Financial Statements. Pro Forma Financial Information and Exhibits. (c) Exhibits. Exhibit 99.1 Press release dated April 22, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Gary DeFazio --------------------------- Gary DeFazio Assistant Secretary Date: April 22, 2003 INDEX TO EXHIBITS Exhibit Number Description of Exhibit - -------------- ---------------------- 99.1 Press release dated April 22, 2003 EX-99 3 ex99-1.txt EXHIBIT 99.1 Contact: Patricia A. Spinella/Investor Relations - 201-847-5453 Charles A. Borgognoni/Corporate Communications - 201-847-6651 EDWARD F. DeGRAAN ELECTED TO BD BOARD OF DIRECTORS Franklin Lakes, NJ (April 22, 2003) - BD (Becton, Dickinson and Company) (NYSE:BDX) has elected Edward F. DeGraan to its Board of Directors, effective May 20, 2003. Mr. DeGraan, 59, is the President and Chief Operating Officer of Gillette Company, a position to which he was named in July 2000. Since joining Gillette in 1968, Mr. DeGraan has served in roles of increasing responsibility, including positions as North Atlantic Group Senior Vice President - Manufacturing and Technical Operations; Executive Vice President - Duracell North Atlantic Group; Executive Vice President - Global Business Management/Gillette Grooming Products and Duracell; and acting Chief Executive Officer. "BD is fortunate to welcome an executive with Ed DeGraan's capabilities and experience to our Board," said Edward J. Ludwig, BD's Chairman, President and Chief Executive Officer. "He brings many years of broad business experience at a leading manufacturing company. Ed's knowledge of global product development and management will be invaluable to BD." Mr. DeGraan is a graduate of Suffolk University. He currently serves on Gillette's Board of Directors; previously, he sat on the board of Network Plus Corporation and was a director of the Boston Private Industry Council. Among his civic and professional affiliations, Mr. DeGraan serves as a trustee of the National Urban League. BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.03 billion. ### -----END PRIVACY-ENHANCED MESSAGE-----